Retraction of: “LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through downregulating SP-A by sponging to miR-424”

Authors

Institutions

Publication Details

Journal
Open Medicine
Published
2025-01-01
DOI
https://doi.org/10.1515/med-2025-9991
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Retraction of: “LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through downregulating SP-A by sponging to miR-424”

Weimin Yu, Hui Li, Jian Hao
Open Medicine
Cancer-related molecular mechanisms research
article

Retraction of: “LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through downregulating SP-A by sponging to miR-424”

Weimin Yu, Hui Li, Jian Hao
article en

Abstract

No abstract available for this paper.
Open MedicineVol. 20(1)
Shanxi Medical University (CN), Shanxi Academy of Medical Sciences (CN)
Openalex Percentile: Top 63%
Cancer-related molecular mechanisms research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Retraction of: “LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through downregulating SP-A by sponging to miR-424” — Weimin Yu, Hui Li, et al. · Open Medicine (2025) | TGRS Research Map | TGRS